We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$229M
1-Year Est. Return
22.02%
This Fund
S&P 500
This Quarter
Est. Return
+16.99%
1 Year Est. Return
+22.02%
3 Year Est. Return
+55.73%
5 Year Est. Return
+56.97%
10 Year Est. Return
–
AUM
$691M
AUM Growth
+$78M
(+13%)
Cap. Flow
+$88.8M
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.5M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$54.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.9M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$16.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$49.3M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$29.8M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$24.1M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$21.5M |
| 5 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 28.66% |
| 2 | Miscellaneous | 22.99% |
| 3 | Technology | 9.15% |
| 4 | Healthcare | 8.01% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Zebra Technologies
ZBRA
$16.9B
| $1.92M | 0.28% |
+75
| New | +$17.6K |
|
|
JWN
77
DELISTED
Nordstrom
JWN
| $1.89M | 0.27% |
121,815
-2,715
| -2% | -$47.8K |
|
78
Delta Air Lines
DAL
$51.8B
| $1.89M | 0.27% |
67,210
+850
| +1% | +$21.6K |
|
79
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $1.73M | 0.25% |
5,622
-516
| -8% | -$151K |
|
80
Kraft Heinz
KHC
$30.1B
| $1.69M | 0.24% |
52,962
-25,486
| -32% | -$765K |
|
|
FRC
81
DELISTED
First Republic Bank
FRC
| $1.65M | 0.24% |
15,541
+9,301
| +149% | +$955K |
|
82
AB InBev
BUD
$158B
| $1.61M | 0.23% |
32,630
-1,070
| -3% | -$50K |
|
83
McDonald's
MCD
$184B
| $1.6M | 0.23% |
8,702
+85
| +1% | +$15.6K |
|
84
iShares Select Dividend ETF
DVY
$24B
| $1.47M | 0.21% |
+18,236
| New | +$1.46M |
|
85
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $1.46M | 0.21% |
+16,000
| New | +$1.46M |
|
86
First Trust Enhanced Short Maturity ETF
FTSM
$6.55B
| $1.46M | 0.21% |
+55,728
| New | +$3.33M |
|
87
Vanguard Morningstar Total Stock Market ETF
VTI
$690B
| $1.39M | 0.2% |
+8,902
| New | +$1.31M |
|
88
Altria Group
MO
$116B
| $1.39M | 0.2% |
35,279
+1,701
| +5% | +$66.4K |
|
89
NextEra Energy
NEE
$175B
| $1.35M | 0.2% |
22,556
+84
| +0.4% | +$5.03K |
|
90
Danaher
DHR
$148B
| $1.35M | 0.2% |
8,619
+182
| +2% | +$26.1K |
|
91
iShares 0-1 Year Treasury Bond ETF
SHV
$20.9B
| $1.27M | 0.18% |
+11,500
| New | +$1.27M |
|
|
DAY
92
DELISTED
Dayforce
DAY
| $1.24M | 0.18% |
+15,618
| New | +$1M |
|
93
iShares Silver Trust
SLV
$32.6B
| $1.23M | 0.18% |
72,256
+72,056
| +36,028% | +$1.1M |
|
94
First Trust Managed Municipal ETF
FMB
$2.03B
| $1.22M | 0.18% |
34,733
-1,705
| -5% | -$91.8K |
|
|
CHL
95
DELISTED
China Mobile Limited
CHL
| $1.21M | 0.17% |
35,905
+3,805
| +12% | +$141K |
|
96
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $1.2M | 0.17% |
+13,864
| New | +$1.2M |
|
97
Enterprise Products Partners
EPD
$84.6B
| $1.17M | 0.17% |
64,605
-4,084
| -6% | -$73K |
|
98
Aflac
AFL
$59.3B
| $1.16M | 0.17% |
32,064
-327
| -1% | -$11.8K |
|
99
CDW
CDW
$19.2B
| $1.15M | 0.17% |
9,871
+9,826
| +21,836% | +$1.06M |
|
100
Chevron
CVX
$415B
| $1.15M | 0.17% |
12,839
+818
| +7% | +$73.2K |
|
Similar funds
IAAG
AAG
WCM
PPA
DCC
SWIM
PRRFG
CAIM
tru Independence's Q2 2020 Portfolio in Review
As of Q2 2020, tru Independence held 960 positions worth $691M, up 13% from $613M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
tru Independence deployed $88.8M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.8% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.
- tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
- tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
- tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
- tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3M.
- tru Independence's ten largest holdings make up 41% of its $691M portfolio in Q2 2020.
- tru Independence opened 207 new positions and closed 53 in Q2 2020.
- tru Independence's portfolio value rose 13% quarter-over-quarter to $691M.
Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.